Suitability of the Use of Low-Molecular-Weight Heparins in the Prevention of Venous Thromboembolism
Adecuación de la utilización de heparinas de bajo peso molecular en la prevención de la enfermedad tromboembólica venosa
M.T. Garrido Martíneza,
, M. Aguayo Canelab, J. Herrera Carranzac, I. Chaparro Morenob, M. Ynfante Ferrusb, J.A. de la Rosa Báezd, L.C. Fernández Lisóna
a Servicio de Farmacia, Hospital Juan Ramón Jiménez, Huelva, Spain
b Servicio de Medicina Interna, Hospital Juan Ramón Jiménez, Huelva, Spain
c Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain
d Servicio de Cirugía General y Digestiva, Hospital Juan Ramón Jiménez, Huelva, Spain
Leído
2506
Vecesse ha leído el artículo
1130
Total PDF
1376
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 6 | 1 | 7 |
| 2025 10 | 68 | 25 | 93 |
| 2025 9 | 50 | 17 | 67 |
| 2025 8 | 58 | 23 | 81 |
| 2025 7 | 49 | 31 | 80 |
| 2025 6 | 35 | 19 | 54 |
| 2025 5 | 46 | 16 | 62 |
| 2025 4 | 41 | 20 | 61 |
| 2025 3 | 46 | 25 | 71 |
| 2025 2 | 39 | 32 | 71 |
| 2025 1 | 35 | 27 | 62 |
| 2024 12 | 30 | 30 | 60 |
| 2024 11 | 40 | 27 | 67 |
| 2024 10 | 27 | 19 | 46 |
| 2024 9 | 34 | 20 | 54 |
| 2024 8 | 39 | 23 | 62 |
| 2024 7 | 21 | 23 | 44 |
| 2024 6 | 26 | 21 | 47 |
| 2024 5 | 35 | 26 | 61 |
| 2024 4 | 31 | 18 | 49 |
| 2024 3 | 22 | 16 | 38 |
| 2024 2 | 28 | 23 | 51 |
| 2024 1 | 16 | 28 | 44 |
| 2023 12 | 25 | 15 | 40 |
| 2023 11 | 27 | 26 | 53 |
| 2023 10 | 22 | 13 | 35 |
| 2023 9 | 32 | 24 | 56 |
| 2023 8 | 10 | 8 | 18 |
| 2023 7 | 15 | 8 | 23 |
| 2023 6 | 16 | 21 | 37 |
| 2023 5 | 13 | 17 | 30 |
| 2023 4 | 12 | 11 | 23 |
| 2023 3 | 12 | 16 | 28 |
| 2023 2 | 8 | 12 | 20 |
| 2022 1 | 9 | 14 | 23 |
| 2022 12 | 10 | 14 | 24 |
| 2022 11 | 8 | 12 | 20 |
| 2022 10 | 7 | 9 | 16 |
| 2022 9 | 8 | 6 | 14 |
| 2022 8 | 9 | 12 | 21 |
| 2022 7 | 30 | 6 | 36 |
| 2022 6 | 16 | 12 | 28 |
| 2022 5 | 7 | 8 | 15 |
| 2022 4 | 8 | 5 | 13 |
| 2022 3 | 8 | 4 | 12 |
| 2022 2 | 5 | 5 | 10 |
| 2021 1 | 5 | 6 | 11 |
| 2021 12 | 5 | 7 | 12 |
| 2021 11 | 3 | 8 | 11 |
| 2021 10 | 6 | 8 | 14 |
| 2021 9 | 8 | 10 | 18 |
| 2021 8 | 6 | 3 | 9 |
| 2021 7 | 2 | 6 | 8 |
| 2021 6 | 5 | 4 | 9 |
| 2021 5 | 5 | 8 | 13 |
| 2021 4 | 3 | 13 | 16 |
| 2021 3 | 6 | 6 | 12 |
| 2021 2 | 3 | 6 | 9 |
| 2020 1 | 3 | 9 | 12 |
| 2020 12 | 3 | 2 | 5 |
| 2020 11 | 5 | 4 | 9 |
| 2020 10 | 3 | 3 | 6 |
| 2020 9 | 6 | 4 | 10 |
| 2020 8 | 7 | 6 | 13 |
| 2020 7 | 3 | 2 | 5 |
| 2020 6 | 3 | 5 | 8 |
| 2020 5 | 5 | 4 | 9 |
| 2020 4 | 3 | 4 | 7 |
| 2020 3 | 2 | 3 | 5 |
| 2020 2 | 2 | 4 | 6 |
| 2020 1 | 3 | 7 | 10 |
| 2019 12 | 5 | 5 | 10 |
| 2019 11 | 1 | 4 | 5 |
| 2019 10 | 6 | 3 | 9 |
| 2019 9 | 3 | 1 | 4 |
| 2019 8 | 1 | 2 | 3 |
| 2019 7 | 14 | 12 | 26 |
| 2019 6 | 1 | 17 | 18 |
| 2019 5 | 11 | 21 | 32 |
| 2019 4 | 2 | 16 | 18 |
| 2019 3 | 2 | 7 | 9 |
| 2019 2 | 1 | 2 | 3 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 1 | 4 | 5 |
| 2018 10 | 5 | 11 | 16 |
| 2018 9 | 2 | 7 | 9 |
| 2018 8 | 3 | 2 | 5 |
| 2018 7 | 2 | 1 | 3 |
| 2018 6 | 4 | 4 | 8 |
| 2018 5 | 2 | 6 | 8 |
| 2018 4 | 0 | 10 | 10 |
| 2018 2 | 0 | 2 | 2 |
| 2018 1 | 0 | 1 | 1 |
| 2017 12 | 0 | 2 | 2 |
| 2017 11 | 0 | 1 | 1 |
| 2017 10 | 2 | 2 | 4 |
| 2017 9 | 4 | 2 | 6 |
| 2017 8 | 1 | 1 | 2 |
| 2017 7 | 2 | 1 | 3 |
| 2017 6 | 10 | 3 | 13 |
| 2017 5 | 5 | 1 | 6 |
| 2017 4 | 6 | 3 | 9 |
| 2017 3 | 8 | 34 | 42 |
| 2017 2 | 7 | 4 | 11 |
| 2016 1 | 4 | 0 | 4 |
| 2016 12 | 6 | 2 | 8 |
| 2016 11 | 3 | 1 | 4 |
| 2016 10 | 2 | 1 | 3 |
| 2016 9 | 1 | 0 | 1 |
| 2016 8 | 2 | 0 | 2 |
| 2016 7 | 2 | 1 | 3 |
Mostrar todo
